These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 38772709)

  • 1. Integrating Omics into Functional Biomarkers of Type 1 Diabetes.
    Long SA; Linsley PS
    Cold Spring Harb Perspect Med; 2024 Jul; 14(7):. PubMed ID: 38772709
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Parallel Multi-Omics in High-Risk Subjects for the Identification of Integrated Biomarker Signatures of Type 1 Diabetes.
    Alcazar O; Hernandez LF; Nakayasu ES; Nicora CD; Ansong C; Muehlbauer MJ; Bain JR; Myer CJ; Bhattacharya SK; Buchwald P; Abdulreda MH
    Biomolecules; 2021 Mar; 11(3):. PubMed ID: 33806609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exploring Computational Data Amplification and Imputation for the Discovery of Type 1 Diabetes (T1D) Biomarkers from Limited Human Datasets.
    Alcazar O; Ogihara M; Ren G; Buchwald P; Abdulreda MH
    Biomolecules; 2022 Oct; 12(10):. PubMed ID: 36291653
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Standardizing T-Cell Biomarkers in Type 1 Diabetes: Challenges and Recent Advances.
    Ahmed S; Cerosaletti K; James E; Long SA; Mannering S; Speake C; Nakayama M; Tree T; Roep BO; Herold KC; Brusko TM
    Diabetes; 2019 Jul; 68(7):1366-1379. PubMed ID: 31221801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Supervised Parametric Learning in the Identification of Composite Biomarker Signatures of Type 1 Diabetes in Integrated Parallel Multi-Omics Datasets.
    Bonnell J; Alcazar O; Watts B; Buchwald P; Abdulreda MH; Ogihara M
    Biomedicines; 2024 Feb; 12(3):. PubMed ID: 38540105
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renal injury in neonates: use of "omics" for developing precision medicine in neonatology.
    Joshi MS; Montgomery KA; Giannone PJ; Bauer JA; Hanna MH
    Pediatr Res; 2017 Jan; 81(1-2):271-276. PubMed ID: 27723726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Uncovering Pathways to Personalized Therapies in Type 1 Diabetes.
    Linsley PS; Greenbaum CJ; Nepom GT
    Diabetes; 2021 Apr; 70(4):831-841. PubMed ID: 33741606
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Omics Data and Their Integrative Analysis to Support Stratified Medicine in Neurodegenerative Diseases.
    La Cognata V; Morello G; Cavallaro S
    Int J Mol Sci; 2021 May; 22(9):. PubMed ID: 34062930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Need for Multi-Omics Biomarker Signatures in Precision Medicine.
    Olivier M; Asmis R; Hawkins GA; Howard TD; Cox LA
    Int J Mol Sci; 2019 Sep; 20(19):. PubMed ID: 31561483
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multi-omics analysis reveals drivers of loss of β-cell function after newly diagnosed autoimmune type 1 diabetes: An INNODIA multicenter study.
    Armenteros JJA; Brorsson C; Johansen CH; Banasik K; Mazzoni G; Moulder R; Hirvonen K; Suomi T; Rasool O; Bruggraber SFA; Marcovecchio ML; Hendricks E; Al-Sari N; Mattila I; Legido-Quigley C; Suvitaival T; Chmura PJ; Knip M; Schulte AM; Lee JH; Sebastiani G; Grieco GE; Elo LL; Kaur S; Pociot F; Dotta F; Tree T; Lahesmaa R; Overbergh L; Mathieu C; Peakman M; Brunak S;
    Diabetes Metab Res Rev; 2024 Jul; 40(5):e3833. PubMed ID: 38961656
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Omics sciences and precision medicine in thyroid cancer.
    Dhuli K; Medori MC; Donato K; Donato K; Maltese PE; Tanzi B; Tezzele S; Mareso C; Miertus J; Generali D; Donofrio CA; Cominetti M; Fioravanti A; Riccio L; Beccari T; Ceccarini MR; Stuppia L; Stuppia L; Gatta V; Cristoni S; Cecchin S; Marceddu G; Bertelli M
    Clin Ter; 2023; 174(Suppl 2(6)):11-20. PubMed ID: 37994744
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Omics for the future in asthma.
    Abdel-Aziz MI; Neerincx AH; Vijverberg SJ; Kraneveld AD; Maitland-van der Zee AH
    Semin Immunopathol; 2020 Feb; 42(1):111-126. PubMed ID: 31942640
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel biomarkers in type 1 diabetes.
    Jin Y; She JX
    Rev Diabet Stud; 2012; 9(4):224-35. PubMed ID: 23804262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biomarkers in type 1 diabetes: application to the clinical trial setting.
    Tooley JE; Herold KC
    Curr Opin Endocrinol Diabetes Obes; 2014 Aug; 21(4):287-92. PubMed ID: 24937037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Precision medicine in colorectal cancer: Leveraging multi-omics, spatial omics, and artificial intelligence.
    Xu Z; Li W; Dong X; Chen Y; Zhang D; Wang J; Zhou L; He G
    Clin Chim Acta; 2024 Jun; 559():119686. PubMed ID: 38663471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bisphenol A (BPA) aggravates multiple low-dose streptozotocin-induced Type 1 diabetes in C57BL/6 mice.
    Cetkovic-Cvrlje M; Thinamany S; Bruner KA
    J Immunotoxicol; 2017 Dec; 14(1):160-168. PubMed ID: 28707492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systematic Assessment of Immune Marker Variation in Type 1 Diabetes: A Prospective Longitudinal Study.
    Speake C; Bahnson HT; Wesley JD; Perdue N; Friedrich D; Pham MN; Lanxon-Cookson E; Kwok WW; Sehested Hansen B; von Herrath M; Greenbaum CJ
    Front Immunol; 2019; 10():2023. PubMed ID: 31572352
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identifying subpathway signatures for individualized anticancer drug response by integrating multi-omics data.
    Xu Y; Dong Q; Li F; Xu Y; Hu C; Wang J; Shang D; Zheng X; Yang H; Zhang C; Shao M; Meng M; Xiong Z; Li X; Zhang Y
    J Transl Med; 2019 Aug; 17(1):255. PubMed ID: 31387579
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Omics sciences and precision medicine in melanoma.
    Medori MC; Donato K; Dhuli K; Maltese PE; Tanzi B; Tezzele S; Mareso C; Miertus J; Generali D; Donofrio CA; Cominetti M; Fioravanti A; Riccio L; Beccari T; Ceccarini MR; Gisondi P; Bellinato F; Stuppia L; Gatta V; Cecchin S; Marceddu G; Bertelli M
    Clin Ter; 2023; 174(Suppl 2(6)):29-36. PubMed ID: 37994746
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Using the T Cell Receptor as a Biomarker in Type 1 Diabetes.
    Nakayama M; Michels AW
    Front Immunol; 2021; 12():777788. PubMed ID: 34868047
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.